Literature DB >> 3060245

Failure of aminoglycoside antibiotics to kill anaerobic, low-pH, and resistant cultures.

D Schlessinger1.   

Abstract

The critical inhibition of ribosome function by aminoglycosides has long been established. But the binding of drug to ribosomes is reversible: why then are aminoglycosides bactericidal? Several groups have shown that irreversible action (lethality) results from irreversible uptake into susceptible cells; conversely, resistance in cases such as anaerobiosis is associated with the failure of uptake. Oddly, the pattern of results excludes all traditional transport mechanisms; most unusual is the apparent dependence of uptake on the interaction of drug with ribosomes. A traditional view that ribosomes may function during uptake as a "sink" for aminoglycosides cannot explain all the data. Instead, the alternative is considered that cycling ribosomes at the cell membrane help to induce "one-way endocytic pores." Although no detailed mechanism is formulated, the results do suggest a way that the permeation of antibiotics might be systematically controllable to render them more cidal.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3060245      PMCID: PMC358029          DOI: 10.1128/CMR.1.1.54

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  28 in total

1.  STREPTOMYCIN ACTION AND ANAEROBIOSIS.

Authors:  M KOGUT; J W LIGHTBROWN; P ISAACSON
Journal:  J Gen Microbiol       Date:  1965-05

2.  Mechanism of streptomycin action on bacteria: a unitary hypothesis.

Authors:  C R SPOTTS; R Y STANIER
Journal:  Nature       Date:  1961-11-18       Impact factor: 49.962

3.  Damage by streptomycin to the cell membrane of Escherichia coli.

Authors:  N ANAND; B D DAVIS
Journal:  Nature       Date:  1960-01-02       Impact factor: 49.962

4.  Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides.

Authors:  B D Davis; L L Chen; P C Tai
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  Polyribosome metabolism in Escherichia coli. I. Extraction of polyribosomes and ribosomal subunits from fragile, growing Escherichia coli.

Authors:  G Mangiarotti; D Schlessinger
Journal:  J Mol Biol       Date:  1966-09       Impact factor: 5.469

6.  Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.

Authors:  J Brajtburg; S Elberg; D R Schwartz; A Vertut-Croquin; D Schlessinger; G S Kobayashi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

7.  Respiration-dependent uptake of dihydrostreptomycin by Escherichia coli. Its irreversible nature and lack of evidence for a uniport process.

Authors:  W W Nichols; S N Young
Journal:  Biochem J       Date:  1985-06-01       Impact factor: 3.857

8.  Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus.

Authors:  E S Eisenberg; L J Mandel; H R Kaback; M H Miller
Journal:  J Bacteriol       Date:  1984-03       Impact factor: 3.490

9.  Streptomycin and infection of Escherichia coli by T6r+ bacteriophage.

Authors:  C E Freda; S S Cohen
Journal:  J Bacteriol       Date:  1966-12       Impact factor: 3.490

10.  Altered translation initiation factor 2 in the cold-sensitive ssyG mutant affects protein export in Escherichia coli.

Authors:  K Shiba; K Ito; Y Nakamura; J Dondon; M Grunberg-Manago
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  23 in total

1.  Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin.

Authors:  Randal Eckert; Keith M Brady; E Peter Greenberg; Fengxia Qi; Daniel K Yarbrough; Jian He; Ian McHardy; Maxwell H Anderson; Wenyuan Shi
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

Review 2.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  Virulence of the Shiga toxin type 2-expressing Escherichia coli O104:H4 German outbreak isolate in two animal models.

Authors:  Tonia Zangari; Angela R Melton-Celsa; Aruna Panda; Nadia Boisen; Mark A Smith; Ivan Tatarov; Louis J De Tolla; James P Nataro; Alison D O'Brien
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

Review 4.  Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.

Authors:  David Lebeaux; Jean-Marc Ghigo; Christophe Beloin
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

Review 5.  Seventy-Five Years of Research on Protein Binding.

Authors:  Axel Dalhoff
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

6.  Interplay of Nitric Oxide Synthase (NOS) and SrrAB in Modulation of Staphylococcus aureus Metabolism and Virulence.

Authors:  Kimberly L James; Austin B Mogen; Jessica N Brandwein; Silvia S Orsini; Miranda J Ridder; Mary A Markiewicz; Jeffrey L Bose; Kelly C Rice
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

7.  Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Enterobacteriaceae.

Authors:  Maria Loose; Isabell Link; Kurt G Naber; Florian M E Wagenlehner
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

Review 8.  Aminoglycosides: the complex problem of antibiotic mechanisms and clinical applications.

Authors:  T Montie; P Patamasucon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

9.  Antimicrobial Treatment Provides a Competitive Advantage to Mycobacterium abscessus in a Dual-Species Biofilm with Pseudomonas aeruginosa.

Authors:  Graciela Rodríguez-Sevilla; Aurélie Crabbé; Marta García-Coca; John Jairo Aguilera-Correa; Jaime Esteban; Concepción Pérez-Jorge
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

10.  Design and activity of a 'dual-targeted' antimicrobial peptide.

Authors:  Jian He; Maxwell H Anderson; Wenyuan Shi; Randal Eckert
Journal:  Int J Antimicrob Agents       Date:  2009-02-01       Impact factor: 5.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.